Structure–Activity Relationships of Inactive‐Conformation Binding EGFR Inhibitors: Linking the ATP and Allosteric Pockets
Archiv der Pharmazie · 2025
DOI: 10.1002/ardp.70027 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, 2025. Verfasst von Surbhi P Chitnis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The State University of New York at Buffalo, Buffalo, New York, USA. Hauptthemen laut MEDLINE: Adenosine Triphosphate, Antineoplastic Agents, ErbB Receptors, Protein Kinase Inhibitors. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) (EXC2180-390900677), National Cancer Institute (R01CA201049, R01C…, NCATS NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
The epidermal growth factor receptor (EGFR) tyrosine kinase is an important therapeutic target in non‐small cell lung cancer (NSCLC). However, the continual emergence of resistance mutations in the treatment of EGFR mutation‐positive NSCLC with currently approved tyrosine kinase inhibitors warrants the development of next‐generation inhibitors. Since research for ATP‐competitive EGFR tyrosine kinase inhibitors (TKIs) that extend into the back pocket has been neglected in the recent past, we survey the extent to which such binding functional groups can be incorporated into an ATP‐site imidazole scaffold. We find that meta ‐substituted amide linkers derivatized with fluorine in 2,6‐positions and/or a hydroxy group in 3‐position of the back pocket phenyl exhibit the highest potency. Structural insights into how the back pocket groups are bound through points of connection provide new directions for the discovery and optimization of inactive conformation targeting agents in EGFR and other kinases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, The State University of New York at Buffalo, Buffalo, New York, USA.
- Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmaceutical Sciences, Eberhard Karls Universität Tübingen, Tübingen, Germany.
- Department of Medicinal Chemistry, Faculty of Medicine, Institute for Biomedical Engineering, Eberhard Karls Universität Tübingen, Tübingen, Germany.
- Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.
- Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", Eberhard Karls Universität Tübingen, Tübingen, Germany.
ORCID-Profile: Surbhi P Chitnis, David E Heppner
Förderung
- This study is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) (EXC2180-390900677), National Cancer Institute (R01CA201049, R01C…
- NCATS NIH HHS
- NCI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Chitnis, S. P., Wittlinger, F., Möllers, M., Hartman, T. J., Günther, M., Eck, M. J., Laufer, S. A., & Heppner, D. E. (2025). Structure–Activity Relationships of Inactive‐Conformation Binding EGFR Inhibitors: Linking the ATP and Allosteric Pockets. Archiv der Pharmazie. https://doi.org/10.1002/ardp.70027
Vancouver
Chitnis SP, Wittlinger F, Möllers M, Hartman TJ, Günther M, Eck MJ, et al. Structure–Activity Relationships of Inactive‐Conformation Binding EGFR Inhibitors: Linking the ATP and Allosteric Pockets. Archiv der Pharmazie. 2025. doi:10.1002/ardp.70027
BibTeX
@article{Chitnis2025,
author = {Chitnis, Surbhi P and Wittlinger, Florian and Möllers, Mareike and Hartman, Tyler J and Günther, Marcel and Eck, Michael J and Laufer, Stefan A and Heppner, David E},
title = {Structure–Activity Relationships of Inactive‐Conformation Binding EGFR Inhibitors: Linking the ATP and Allosteric Pockets},
journal = {Archiv der Pharmazie},
year = {2025},
doi = {10.1002/ardp.70027}
}
EUVIMED